Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
02 2021
Historique:
received: 03 07 2020
revised: 20 07 2020
accepted: 21 07 2020
pubmed: 25 7 2020
medline: 15 1 2021
entrez: 25 7 2020
Statut: ppublish

Résumé

Knowledge of the precise timing of SARS-CoV-2 infection may be of clinical and epidemiological relevance. The presence of low-avidity IgGs has conventionally been considered an indicator of recent infection. Here, we carried out qualitative assessment of SARS-CoV-2-specific antibody avidity using an urea (6M) dissociation test performed on a lateral flow immunochromatographic IgG/IgM device. We included a total of 76 serum specimens collected from 57 COVID-19 patients, of which 39 tested positive for both IgG and IgM and 37 only for IgG. Sera losing IgG reactivity after urea treatment (n = 28) were drawn significantly earlier (P = .04) after onset of symptoms than those which preserved it (n = 48). This assay may be helpful to estimate the time of acquisition of infection in patients with mild to severe COVID-19.

Identifiants

pubmed: 32706420
doi: 10.1002/jmv.26344
pmc: PMC7405485
doi:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0
Immunoglobulin M 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1141-1144

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32277023
J Med Virol. 2020 Nov;92(11):2306-2307
pubmed: 32369202
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Expert Opin Med Diagn. 2007 Dec;1(4):511-9
pubmed: 23496357
PLoS One. 2020 Dec 10;15(12):e0242958
pubmed: 33301459
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Med Virol. 2020 Oct;92(10):1799-1801
pubmed: 32320082
Annu Rev Genet. 2007;41:107-20
pubmed: 17576170
J Med Virol. 2021 Feb;93(2):1141-1144
pubmed: 32706420
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
J Allergy Clin Immunol. 2020 Jul;146(1):35-43
pubmed: 32479758

Auteurs

Arantxa Valdivia (A)

Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.

Ignacio Torres (I)

Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.

Dixie Huntley (D)

Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.

María J Alcaraz (MJ)

Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.

Eliseo Albert (E)

Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.

Javier Colomina (J)

Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.

Josep Ferrer (J)

Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.

Arturo Carratalá (A)

Medical Biochemistry and Clinical Analysis Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.

David Navarro (D)

Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH